ID   RASA3_HUMAN             Reviewed;         834 AA.
AC   Q14644; A6NL15; F8W6X8; Q8IUY2;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 3.
DT   18-JUN-2025, entry version 209.
DE   RecName: Full=Ras GTPase-activating protein 3;
DE   AltName: Full=GAP1(IP4BP);
DE   AltName: Full=Ins P4-binding protein;
GN   Name=RASA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Peripheral blood;
RX   PubMed=7637787; DOI=10.1038/376527a0;
RA   Cullen P.J., Hsuan J.J., Truong O., Letcher A.J., Jackson T.J.,
RA   Dawson A.P., Irvine R.F.;
RT   "Identification of a specific Ins(1,3,4,5)P4-binding protein as a member of
RT   the GAP1 family.";
RL   Nature 376:527-530(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   MUTAGENESIS.
RC   TISSUE=Blood;
RX   PubMed=9382842; DOI=10.1016/s0960-9822(06)00423-4;
RA   Lockyer P.J., Bottomley J.R., Reynolds J.S., McNulty T.J.,
RA   Venkateswarlu K., Potter B.V.L., Dempsey C.E., Cullen P.J.;
RT   "Distinct subcellular localisations of the putative inositol 1,3,4,5-
RT   tetrakisphosphate receptors GAP1(IP4BP) and GAP1m result from the
RT   GAP1(IP4BP) PH domain directing plasma membrane targeting.";
RL   Curr. Biol. 7:1007-1010(1997).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-110, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   ACETYLATION AT ALA-2, AND CLEAVAGE OF INITIATOR METHIONINE.
RX   PubMed=25489052; DOI=10.1093/hmg/ddu611;
RA   Myklebust L.M., Van Damme P., Stoeve S.I., Doerfel M.J., Abboud A.,
RA   Kalvik T.V., Grauffel C., Jonckheere V., Wu Y., Swensen J., Kaasa H.,
RA   Liszczak G., Marmorstein R., Reuter N., Lyon G.J., Gevaert K., Arnesen T.;
RT   "Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-
RT   acetylation defects.";
RL   Hum. Mol. Genet. 24:1956-1976(2015).
CC   -!- FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Binds
CC       inositol tetrakisphosphate (IP4) with high affinity. Might be a
CC       specific IP4 receptor.
CC   -!- SUBCELLULAR LOCATION: Cell membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14644-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14644-2; Sequence=VSP_056141;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X89399; CAA61580.1; -; mRNA.
DR   EMBL; AK289746; BAF82435.1; -; mRNA.
DR   EMBL; AK294913; BAH11922.1; -; mRNA.
DR   EMBL; AL161774; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX537329; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC038456; AAH38456.1; -; mRNA.
DR   EMBL; BC047242; AAH47242.1; -; mRNA.
DR   CCDS; CCDS32016.1; -. [Q14644-1]
DR   RefSeq; NP_001307750.1; NM_001320821.1.
DR   RefSeq; NP_001307751.1; NM_001320822.2. [Q14644-2]
DR   RefSeq; NP_031394.2; NM_007368.3. [Q14644-1]
DR   RefSeq; XP_011533143.1; XM_011534841.4. [Q14644-2]
DR   RefSeq; XP_011533144.1; XM_011534842.3. [Q14644-2]
DR   RefSeq; XP_047286111.1; XM_047430155.1. [Q14644-2]
DR   RefSeq; XP_054187692.1; XM_054331717.1. [Q14644-2]
DR   RefSeq; XP_054187693.1; XM_054331718.1. [Q14644-2]
DR   RefSeq; XP_054187695.1; XM_054331720.1. [Q14644-2]
DR   RefSeq; XP_054230208.1; XM_054374233.1. [Q14644-2]
DR   RefSeq; XP_054230209.1; XM_054374234.1. [Q14644-2]
DR   RefSeq; XP_054230211.1; XM_054374236.1. [Q14644-2]
DR   AlphaFoldDB; Q14644; -.
DR   SMR; Q14644; -.
DR   BioGRID; 116497; 33.
DR   FunCoup; Q14644; 741.
DR   IntAct; Q14644; 3.
DR   STRING; 9606.ENSP00000335029; -.
DR   iPTMnet; Q14644; -.
DR   PhosphoSitePlus; Q14644; -.
DR   BioMuta; RASA3; -.
DR   DMDM; 206729910; -.
DR   jPOST; Q14644; -.
DR   MassIVE; Q14644; -.
DR   PaxDb; 9606-ENSP00000335029; -.
DR   PeptideAtlas; Q14644; -.
DR   ProteomicsDB; 29852; -.
DR   ProteomicsDB; 60089; -. [Q14644-1]
DR   Pumba; Q14644; -.
DR   Antibodypedia; 26027; 286 antibodies from 32 providers.
DR   DNASU; 22821; -.
DR   Ensembl; ENST00000334062.8; ENSP00000335029.7; ENSG00000185989.11. [Q14644-1]
DR   Ensembl; ENST00000630618.2; ENSP00000486064.1; ENSG00000280477.2. [Q14644-1]
DR   GeneID; 22821; -.
DR   KEGG; hsa:22821; -.
DR   MANE-Select; ENST00000334062.8; ENSP00000335029.7; NM_007368.4; NP_031394.2.
DR   UCSC; uc001vui.4; human. [Q14644-1]
DR   AGR; HGNC:20331; -.
DR   CTD; 22821; -.
DR   DisGeNET; 22821; -.
DR   GeneCards; RASA3; -.
DR   HGNC; HGNC:20331; RASA3.
DR   HPA; ENSG00000185989; Low tissue specificity.
DR   MIM; 605182; gene.
DR   neXtProt; NX_Q14644; -.
DR   OpenTargets; ENSG00000185989; -.
DR   PharmGKB; PA134905447; -.
DR   VEuPathDB; HostDB:ENSG00000185989; -.
DR   eggNOG; KOG2059; Eukaryota.
DR   GeneTree; ENSGT00940000157953; -.
DR   HOGENOM; CLU_008096_1_1_1; -.
DR   InParanoid; Q14644; -.
DR   OMA; CKEEYMA; -.
DR   OrthoDB; 1562946at2759; -.
DR   PAN-GO; Q14644; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q14644; -.
DR   TreeFam; TF105302; -.
DR   PathwayCommons; Q14644; -.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   SignaLink; Q14644; -.
DR   BioGRID-ORCS; 22821; 25 hits in 1162 CRISPR screens.
DR   ChiTaRS; RASA3; human.
DR   GeneWiki; RASA3; -.
DR   GenomeRNAi; 22821; -.
DR   Pharos; Q14644; Tbio.
DR   PRO; PR:Q14644; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q14644; protein.
DR   Bgee; ENSG00000185989; Expressed in granulocyte and 97 other cell types or tissues.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005246; F:calcium channel regulator activity; IDA:BHF-UCL.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:InterPro.
DR   GO; GO:0030168; P:platelet activation; IDA:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd08401; C2A_RasA2_RasA3; 1.
DR   CDD; cd04010; C2B_RasA3; 1.
DR   CDD; cd13371; PH_GAP1_mammal-like; 1.
DR   CDD; cd05134; RasGAP_RASA3; 1.
DR   FunFam; 1.10.506.10:FF:000011; Ras GTPase-activating protein 2 isoform 3; 1.
DR   FunFam; 2.30.29.30:FF:000144; Ras GTPase-activating protein 2 isoform 3; 1.
DR   FunFam; 2.60.40.150:FF:000086; Ras GTPase-activating protein 2 isoform 3; 1.
DR   FunFam; 2.60.40.150:FF:000144; RAS p21 protein activator 3; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 2.
DR   Gene3D; 1.10.506.10; GTPase Activation - p120gap, domain 1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR039360; Ras_GTPase.
DR   InterPro; IPR037774; RASA3_PH.
DR   InterPro; IPR023152; RasGAP_CS.
DR   InterPro; IPR001936; RasGAP_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   PANTHER; PTHR10194:SF53; RAS GTPASE-ACTIVATING PROTEIN 3; 1.
DR   PANTHER; PTHR10194; RAS GTPASE-ACTIVATING PROTEINS; 1.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00168; C2; 2.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00616; RasGAP; 2.
DR   PRINTS; PR00402; TECBTKDOMAIN.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00239; C2; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00323; RasGAP; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 2.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50004; C2; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00509; RAS_GTPASE_ACTIV_1; 1.
DR   PROSITE; PS50018; RAS_GTPASE_ACTIV_2; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane; GTPase activation;
KW   Membrane; Metal-binding; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Repeat; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25489052"
FT   CHAIN           2..834
FT                   /note="Ras GTPase-activating protein 3"
FT                   /id="PRO_0000056642"
FT   DOMAIN          1..112
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          123..263
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          346..561
FT                   /note="Ras-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   DOMAIN          576..677
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   ZN_FING         679..715
FT                   /note="Btk-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         687
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         698
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         699
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         709
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   SITE            371
FT                   /note="Arginine finger; crucial for GTP hydrolysis by
FT                   stabilizing the transition state"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:25489052"
FT   MOD_RES         66
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60790"
FT   MOD_RES         77
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60790"
FT   MOD_RES         110
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18220336"
FT   MOD_RES         809
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         833
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60790"
FT   VAR_SEQ         1..32
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056141"
FT   MUTAGEN         599
FT                   /note="K->Q: No binding to IP4 and loss of plasma membrane
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:9382842"
FT   MUTAGEN         600
FT                   /note="K->Q: No binding to IP4 and loss of plasma membrane
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:9382842"
FT   MUTAGEN         601
FT                   /note="R->Q: No binding to IP4 and loss of plasma membrane
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:9382842"
FT   CONFLICT        785..786
FT                   /note="AG -> RW (in Ref. 1; CAA61580)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   834 AA;  95699 MW;  97C3467C957DA8A1 CRC64;
     MAVEDEGLRV FQSVKIKIGE AKNLPSYPGP SKMRDCYCTV NLDQEEVFRT KIVEKSLCPF
     YGEDFYCEIP RSFRHLSFYI FDRDVFRRDS IIGKVAIQKE DLQKYHNRDT WFQLQHVDAD
     SEVQGKVHLE LRLSEVITDT GVVCHKLATR IVECQGLPIV NGQCDPYATV TLAGPFRSEA
     KKTKVKRKTN NPQFDEVFYF EVTRPCSYSK KSHFDFEEED VDKLEIRVDL WNASNLKFGD
     EFLGELRIPL KVLRQSSSYE AWYFLQPRDN GSKSLKPDDL GSLRLNVVYT EDHVFSSDYY
     SPLRDLLLKS ADVEPVSASA AHILGEVCRE KQEAAVPLVR LFLHYGRVVP FISAIASAEV
     KRTQDPNTIF RGNSLASKCI DETMKLAGMH YLHVTLKPAI EEICQSHKPC EIDPVKLKDG
     ENLENNMENL RQYVDRVFHA ITESGVSCPT VMCDIFFSLR EAAAKRFQDD PDVRYTAVSS
     FIFLRFFAPA ILSPNLFQLT PHHTDPQTSR TLTLISKTVQ TLGSLSKSKS ASFKESYMAT
     FYEFFNEQKY ADAVKNFLDL ISSSGRRDPK SVEQPIVLKE GFMIKRAQGR KRFGMKNFKK
     RWFRLTNHEF TYHKSKGDQP LYSIPIENIL AVEKLEEESF KMKNMFQVIQ PERALYIQAN
     NCVEAKDWID ILTKVSQCNQ KRLTVYHPSA YLSGHWLCCR APSDSAPGCS PCTGGLPANI
     QLDIDGDRET ERIYSLFNLY MSKLEKMQEA CGSKSVYDGP EQEEYSTFVI DDPQETYKTL
     KQVIAGVGAL EQEHAQYKRD KFKKTKYGSQ EHPIGDKSFQ NYIRQQSETS THSI
//
